Trytosaveabit commented on a stock · May 7 08:00

Update

$NeuroSense Therapeutics(NRSN.US)$ Neurosense Therapeutics Ltd: Announces New Analyses From Its Phase 2B Paradigm Clinical Trial! Slowed disease progression by 43%

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

960 Views

Comment

Trytosaveabit

1907Followers

30Following

23KVisitors